市場調查報告書
商品編碼
1256372
體脂測量市場——按產品(生物阻抗分析儀、卡尺、靜水壓稱重、空氣置換體積描記術、DEXA)按最終用途(醫院、診所、健身中心)分類,全球預測,2023-2032 年Body Fat Measurement Market - By Product (Bioimpedance Analyzers, Calipers, Hydrostatic Weighing, Air-Displacement Plethysmography, Dual-energy X-ray absorptiometry (DEXA)), By End-use (Hospitals, Clinics, Fitness Centers) & Global Forecast, 2023 - 2032 |
體脂測量市場預計將從 2023 年到 2032 年顯著增長,因為能夠在臨床環境中測量多個身體參數的體脂測量設備不斷創新。.
此外,幾家主要公司積極參與先進 BIA 設備的開發也將對行業前景產生積極影響。
此外,射頻、超聲波、冷凍溶脂和激光等多種非侵入性治療現在可用於治療常見的問題部位,無需開刀手術。以支持體脂測量市場的增長潛力.
總體而言,體脂測量市場按產品、最終用途和區域進行細分。
基於產品,DEXA(雙能 X 射線吸收測定)細分市場預計在 2023 年至 2032 年期間的複合年增長率將超過 8%。 DEXA 為骨骼和組織成分提供準確的身體成分掃描,包括骨礦物質密度 (BMD)、脂肪和瘦體重。 它還有助於測量全身脂肪、瘦組織、內臟脂肪和骨密度。 單次測量可提供高度準確的結果,並重現脂肪在全身的正確分佈。
DEXA 掃描的高可靠性、安全性和低患者負擔等優勢將在未來幾年促進該細分市場的增長。
考慮到最終用途,到 2032 年,診所部分的價值預計將超過 4 億美元。 肥胖相關疾病的增加和就診機會的增加,尤其是在新興國家,預計將在未來幾年推動該行業的增長。 身體質量指數(BMI)方法的引入,提高了體脂測量的準確性,正在取得進展,並且來診所的患者數量也在增加。
在區域方面,由於該地區越來越多地採用技術創新設備,預計歐洲體脂測量行業將在 2023 年至 2032 年顯著增長。 不言而喻,由於久坐不動的生活方式導致的肥胖率上升以及歐洲國家迅速推出的國家肥胖管理服務也將在未來幾年推動體脂測量業務的增長。 根據美國國立衛生研究院的數據,53.5% 的德國人口超重,肥胖患病率上升到成年人口的 19%。
此外,該地區人民意識的增強和先進技術的不斷引進將推動該地區未來的市場增長。
Body Fat Measurement Market is projected to grow notably during 2023-2032 due to constant technological innovations in body fat measurement devices that can measure several body parameters in clinical settings. In addition, active focus of several key players in the development of advanced BIA devices will positively favor the industry outlook.
Moreover, the availability of various non-invasive treatments such as radio frequency, ultrasound, cryolipolysis, and lasers that focus on common trouble spots without the need for knife procedures would support the body fat measurement market growth potential.
Overall, the body fat measurement market is categorized in terms of product, end-use, and region.
Based on the product, the Dual Energy X-Ray Absorptiometry (DEXA) segment is anticipated to depict over 8% CAGR during 2023-2032. DEXA offers accurate body composition scans on bone and tissue composition, such as bone mineral density (BMD), fat, and lean tissue mass. The scan also helps measure whole-body fat, lean tissue, visceral fat, and bone density. It delivers results with high precision in a single measurement and replicates the proper distribution of fat throughout the body.
DEXA scan benefits such as high reliability, safety, and lesser burden on the patients will augment segmental growth in the coming years.
Considering the end-use, the clinics segment is expected to be valued at over USD 400 million by 2032. Increasing cases of obesity-related diseases and improving access to clinics especially in emerging economies, will favor segment growth over the ensuing years. The rising deployment of the body mass index (BMI) technique with more accurate technology for measuring body fat has increased the influx of patient count in clinics.
Regionally, the Europe body fat measurement industry will grow considerably during 2023-2032 owing to the increasing adoption of technologically innovative devices across the region. Not to mention, the growing cases of obesity owing to a sedentary lifestyle and the surging deployment of national obesity management services in European countries will assist the body fat measurement business growth over the coming years. As per NIH, 53.5% of the German population is overweight, with the prevalence of obesity being 19% in the adult population.
In addition, increasing awareness and constant adoption of advanced technologies across the region will push the regional market growth in the coming future.